Mind Medicine (MindMed) Management
Management criteria checks 3/4
Mind Medicine (MindMed)'s CEO is Rob Barrow, appointed in Jun 2021, has a tenure of 2.92 years. total yearly compensation is $2.14M, comprised of 27.9% salary and 72.1% bonuses, including company stock and options. directly owns 0.26% of the company’s shares, worth $1.76M. The average tenure of the management team and the board of directors is 2.1 years and 2.7 years respectively.
Key information
Rob Barrow
Chief executive officer
US$2.1m
Total compensation
| CEO salary percentage | 27.9% |
| CEO tenure | 2.9yrs |
| CEO ownership | 0.3% |
| Management average tenure | 2.1yrs |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
Mind Medicine: GAD Program Success Continues With BTD And Positive Treatment Data
Apr 04Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts
Feb 02Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans
May 23
We're Hopeful That Mind Medicine (MindMed) (NASDAQ:MNMD) Will Use Its Cash Wisely
Feb 07MindMed: Not The Horse To Back If You're Looking To Buy Psychedelics
Oct 19MindMed announces proposed public offering of common shares
Sep 27MindMed doses first patient in phase 1 trial examining psychedelic MDMA-like substances
Sep 20MindMed regains compliance with Nasdaq's minimum bid price listing requirement
Sep 14MindMed: Confusing MEME Rally Hides A Company That Looks Empty Of Value
Sep 04Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans
Aug 26Magic mushrooms psychedelic compound can help with treatment of alcohol use disorder
Aug 24MindMed soars 71% as it appears to be following in Bed Bath & Beyond's footsteps
Aug 18Mind Medicine GAAP EPS of -$0.04 beats by $0.01
Aug 11Mind Medicine announces 1-for-15 reverse stock split
Aug 04MindMed: Another Psychedelic Medicine Play Trading At A Potential Discount
Jul 12Mind Medicine: It's Best To Stay Far Away From This Risky Psychedelic Stock
Apr 20MindMed: Falling Uncontrollably
Jan 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$599k | -US$96m |
| Sep 30 2023 | n/a | n/a | -US$77m |
| Jun 30 2023 | n/a | n/a | -US$75m |
| Mar 31 2023 | n/a | n/a | -US$63m |
| Dec 31 2022 | US$5m | US$672k | -US$57m |
| Sep 30 2022 | n/a | n/a | -US$69m |
| Jun 30 2022 | n/a | n/a | -US$69m |
| Mar 31 2022 | n/a | n/a | -US$98m |
| Dec 31 2021 | US$12m | US$350k | -US$93m |
Compensation vs Market: Rob's total compensation ($USD2.14M) is below average for companies of similar size in the US market ($USD3.42M).
Compensation vs Earnings: Rob's compensation has been consistent with company performance over the past year.
CEO
Rob Barrow (34 yo)
2.9yrs
Tenure
US$2,143,133
Compensation
Mr. Robert Barrow, also known as Rob, serves as Chief Executive Officer at Mind Medicine (MindMed) Inc since June 9, 2021 and serves a its Director since December 13, 2021. He served as Chief Development O...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.9yrs | US$2.14m | 0.26% $ 1.8m | |
| Chief Financial Officer | 2yrs | US$1.14m | 0.045% $ 306.4k | |
| Chief Medical Officer | 3.3yrs | US$1.04m | 0.098% $ 670.3k | |
| Executive President | 3.8yrs | US$2.66m | 0.13% $ 856.8k | |
| Co-Founder & Clinical Advisor | no data | US$501.19k | no data | |
| Co-founder | no data | no data | no data | |
| VP & Chief Accounting Officer | 1.5yrs | no data | 0.048% $ 327.9k | |
| Chief Legal Officer & Corporate Secretary | 1.1yrs | no data | no data | |
| Chief Commercial Officer | 2.1yrs | no data | no data |
2.1yrs
Average Tenure
52yo
Average Age
Experienced Management: MNMD's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.4yrs | US$2.14m | 0.26% $ 1.8m | |
| Independent Chairperson | 2.7yrs | US$196.20k | 0.018% $ 124.9k | |
| Independent Director | less than a year | US$179.01k | no data | |
| Independent Director | 1.8yrs | US$148.70k | 0.017% $ 116.5k | |
| Chair of Scientific Advisory Board | 3.2yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.9yrs | no data | no data | |
| Independent Vice Chairman | 2.7yrs | US$186.20k | 0.016% $ 111.3k | |
| Independent Director | 1.8yrs | US$148.70k | 0.017% $ 116.5k | |
| Member of Scientific Advisory Board | 2.9yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.5yrs | no data | no data |
2.7yrs
Average Tenure
62.5yo
Average Age
Experienced Board: MNMD's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.